DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 5Dr. Reddy's Laboratories
02 1Supriya Lifescience
03 2Accord Healthcare Pty. Ltd.
04 23Accord healthcare
05 4Accure Labs
06 2Actavis Inc
07 2Alembic Pharmaceuticals Limited
08 1Almaject
09 2Amneal Pharmaceuticals
10 3Aurobindo Pharma Limited
11 2Ayana Pharma
12 6BAXTER HEALTHCARE PTY LTD
13 2Baxter HealthCare South Africa (Pty) Ltd
14 5Baxter Healthcare Corporation
15 3Bayer AG
16 1Bluepharma
17 3Bristol Myers Squibb
18 1Cheplapharm Arzneimittel Gmbh
19 2Cipla Medpro South Africa
20 1Copharma Aps
21 1Deva Holding AS
22 1Dr Reddy's Laboratories (Pty) Ltd
23 3EBEWE Pharma Ges.m.b.H Nfg. KG
24 2Flagship Biotech International Pvt. Ltd
25 1Fresenius Kabi USA
26 2Fresenius SE & Co. KGaA
27 1GLAND PHARMA LIMITED
28 6GetWell Pharmaceutical
29 1Health Biotech
30 1Healthcare Pharmaceuticals
31 5Hikma Pharmaceuticals
32 1Intelliscend
33 2Janssen-Cilag
34 2Jodas Expoim Pvt. Ltd
35 3Key Oncologics
36 2Lupin Ltd
37 3Naprod Life Sciences
38 2Nishchay Pharmaceuticals Pvt. Ltd.
39 4Oethmaan Biosims
40 1PHARMOBEDIENT
41 1Panacea Biotec Limited
42 4Pfizer Consumer Healthcare
43 30Pfizer Inc
44 5Pharmachemie
45 8Pharmachemie (Pty) Ltd
46 1Pharmaplan
47 1Powercliff Limited
48 3SEACROSS PHARMACEUTICALS
49 1STADA Arzneimittel
50 1Sagent Pharmaceuticals
51 3Sakar Healthcare
52 8Sandoz B2B
53 1Sanoswiss Uab
54 10Sun Pharmaceutical Industries Limited
55 1Taro Pharmaceutical Industries
56 15Teva Pharmaceutical Industries
57 4TherDose Pharma
58 4Viatris
59 2Vinkem Labs Ltd
60 1Zhejiang Hisun Pharmaceutical
61 2Zydus Lifesciences
62 9Blank
01 1Concentrate For Dispersion For Infusion
02 12Concentrate For Solution For Infusion
03 4Concentrate to the infusion fluid
04 1Concentrate to the infusion fluid, resolution
05 1Concentrated Solution
06 1Concentrated Solution Perfusion
07 1Doxorubicin 100Mg 50Ml 1 Units Parenteral Use
08 6Doxorubicin 10Mg 5Ml 1 Units Parenteral Use
09 3Doxorubicin 200Mg 100Ml 1 Units Parenteral Use
10 1Doxorubicin 20Mg 10Ml 1 Units Parenteral Use
11 1Doxorubicin 50Mg 1 Unit Parenteral Use
12 1Doxorubicin 50Mg 2 Units Parenteral Use
13 4Doxorubicin 50Mg 25Ml 1 Units Parenteral Use
14 11INF
15 23INJ
16 16INJECTABLE, LIPOSOMAL;INJECTION
17 38INJECTABLE;INJECTION
18 6INJECTION
19 1Infusion Dispersion
20 2Injectable Infusion
21 3Injectable Intravenous Solution
22 4Injectable Solution
23 1Injectable; Injection
24 22Injection
25 5Injection fluid, resolution
26 1Liposomal Injection
27 1Liposome Injection
28 1Liquid Injection
29 2Lyo.Inj
30 2Lyophilised Injection
31 1POI
32 2POWDER FOR SOLUTION
33 2Powder For Concentrate For Solution For Infusion
34 1Powder For Oral Solution
35 1Powder For Solution For Injection
36 1Powder and liquids to concentrate for infusion, liposomaldispersjon
37 2Powder for injection fluid, resolution
38 2SOL
39 6SOLUTION
40 2SUSPENSION
41 14Solution For Injection
42 1Vial
43 1Vial Of Lyophilised
44 18Blank
01 21Allowed
02 7Approved
03 22DISCN
04 7Deregistered
05 45Generic
06 2Lead Market Dossiers- Approved in US and Under review in EU
07 1Lead Market Dossiers- Filed
08 6Originator
09 32RX
10 87Blank
01 11 Farmiblastina 10Mg Vial 1 Blister Powder And Solvent For Solution For Injection
02 11 Farmiblastina 10Mg Vial Solution + 1 Blister
03 11 Farmiblastina 50Mg Vial Of Lyophilised
04 11 Farmiblastina Solution 50Mg Vial 25Ml
05 2ADRIAMYCIN PFS
06 10Adriamycin
07 2Adriblastin RD
08 3Adriblastin Solution
09 5Adriblastina
10 1Adriblastina CSV 10mg/5ml
11 1Adriblastina CSV 50mg/25ml
12 1Adriblastina RD 10mg
13 1Adriblastina RD 50mg
14 1CAELYX
15 11Caelyx
16 1Caelyx Pegylated Liposomal
17 1Celdoxome Pegylated Liposomal
18 1Cipla Doxorubicin 10
19 1Cipla Doxorubicin 50
20 2DOXIL (LIPOSOMAL)
21 1DOXOPEG
22 4DOXORUBA
23 1DOXORUBICIN
24 1DOXORUBICIN -SOL PCH 10MG
25 1DOXORUBICIN 10mg/5ml FRESENIUS
26 1DOXORUBICIN 50mg/25ml FRESENIUS
27 33DOXORUBICIN HYDROCHLORIDE
28 14DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
29 2DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
30 1DOXORUBICIN HYDROCHLORIDE INJECTION
31 1DOXORUBICIN INJECTION, BP
32 1DOXORUBICIN-SOL PCH 50MG
33 2DOXOTHER
34 1Doxolip
35 1Doxonish 10
36 1Doxonish 50
37 10Doxorubicin
38 1Doxorubicin "Ebewe" 10mg (5ml vial)
39 1Doxorubicin "Ebewe" 50mg (25ml vial)
40 1Doxorubicin - Pch 10
41 2Doxorubicin ACC
42 10Doxorubicin Accord
43 1Doxorubicin Accord 10mg/5ml
44 1Doxorubicin Accord 2Mg/Ml 1 Vial 50Mg/25Ml Concentr Solution Perf Efg
45 1Doxorubicin Accord 2Mg/Ml 1 Vial 50Ml Drip Soluc Concentr Efg
46 1Doxorubicin Accord 50mg/25ml
47 2Doxorubicin Accord liposomal
48 1Doxorubicin Aurovitas 2Mg/Ml 25Ml Vial 1 (50Mg/25Ml) Concentrated Sun Perf Efg
49 1Doxorubicin Aurovitas 2Mg/Ml 50Ml Vial 1 (100Mg/50Ml) Grant Sun Perf Efg
50 1Doxorubicin Copharma
51 4Doxorubicin Ebewe
52 2Doxorubicin Mylan
53 1Doxorubicin Pch
54 1Doxorubicin Pch 10 10Mg Vial
55 1Doxorubicin Pch 50
56 1Doxorubicin Rtu
57 1Doxorubicin Rtu 10-5 5Ml
58 1Doxorubicin Rtu 200-100 100Ml
59 1Doxorubicin Rtu 50-25 25Ml
60 4Doxorubicin Sandoz eco
61 1Doxorubicin Sanoswiss
62 1Doxorubicin Stada
63 1Doxorubicin Tedec 2Mg/Ml 25Ml Vial Soluc 1 Pb
64 2Doxorubicin Teva
65 1Doxorubicin hcl faulfing powder vial
66 1Doxorubicin-Hexal 10Mg/5Ml
67 1Doxorubicin-Hexal 50Mg/25Ml
68 4Doxorubicin-Teva
69 1Doxred 10 Lyophilized Powder
70 1Doxred 10mg/5ml
71 1Doxred 50 Lyophilized Powder
72 1Doxred 50mg/25ml
73 2I-DOX
74 6Liposomal Doxorubicin SUN
75 2Myocet
76 1Myocet Liposomal
77 3RUBEX
78 1Rubexet 10mg/5ml
79 1Rubexet 200mg/100ml
80 1Rubexet 50mg/25ml
81 1Sopilcin 20 mg/10 ml
82 1TARO-DOXORUBICIN LIPOSOMAL
83 1Zolsketil Pegylated Liposomal
84 29Blank
01 18Australia
02 7Canada
03 35India
04 17Italy
05 13Norway
06 1Portugal
07 37South Africa
08 9Spain
09 14Sweden
10 21Switzerland
11 1Turkey
12 54USA
13 3United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG/10ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG/25ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 1995-11-17
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2000-06-13
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1985-05-20
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/VIAL
Packaging :
Approval Date : 1987-07-22
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG/ML
Packaging :
Approval Date : 1987-12-23
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 200MG/100ML
Packaging :
Approval Date : 1988-05-03
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/75ML
Packaging :
Approval Date : 2011-03-28
Application Number : 50629
Regulatory Info : DISCN
Registration Country : USA
